Stockreport
4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026 [Yahoo! Finance]
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations: ir.edwards.com
Notably, the Dow Jones U.S. Select Medical Equipment Index has advanced about 8% in 2025, underscoring the sector's ability to adapt, innovate and deliver consistent performance despite a challenging operating environment. The MedTech industry is heading into 2026 with improving fundamentals after working through supply-chain disruptions, labor constraints and uneven hospital spending over the past few years. Procedure volumes are normalizing, elective surgery backlogs are easing and healthcare providers are increasingly prioritizing technologies that enhance clinical outcomes while improving operational efficiency. This environment favors large-cap MedTech companies with diversified portfolios, strong execution capabilities and the scale to translate innovation into consistent earnings growth. A key growth driver in 2026 is likely to be the expanding role of artificial intelligence, software and data-driven solutions across the MedTech value chain. AI-enabled imaging, diagnostics
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | EW | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
EW alerts
EW alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
NEWS
NEWS
- Relief Cardiovascular Appoints Harry Rowland as Chairman of the Board [Yahoo! Finance][Yahoo! Finance]
- Edwards Lifesciences (NYSE:EW) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $90.00.[MarketBeat]
- Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Wells Fargo & Company.[MarketBeat]
- Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference[Business Wire]
- Transcatheter Heart Valve Replacement Market Size to Reach USD 19.98 Billion by 2033, Growing at a CAGR of 15.32% – SNS Insider [Yahoo! Finance][Yahoo! Finance]
- More
EW
SEC Filings
SEC Filings
- 12/12/25 - Form 4
- 12/12/25 - Form 4
- 12/12/25 - Form 4
- EW's page on the SEC website
- More